Aimei Health Technology Co., Ltd. (NASDAQ:AFJK – Get Free Report) was the target of a large increase in short interest in the month of June. As of June 30th, there was short interest totaling 4,249 shares, an increase of 94.6% from the June 15th total of 2,184 shares. Based on an average daily volume of 11,212 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.1% of the shares of the stock are sold short.
Hedge Funds Weigh In On Aimei Health Technology
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Clear Street Group Inc. lifted its position in Aimei Health Technology by 36.5% in the 4th quarter. Clear Street Group Inc. now owns 83,337 shares of the company’s stock worth $5,334,000 after buying an additional 22,294 shares during the last quarter. Jane Street Group LLC bought a new stake in shares of Aimei Health Technology in the 4th quarter worth approximately $302,000. Geode Capital Management LLC bought a new position in shares of Aimei Health Technology during the 4th quarter valued at $413,000. Quarry LP grew its holdings in shares of Aimei Health Technology by 6.4% during the 3rd quarter. Quarry LP now owns 167,081 shares of the company’s stock valued at $1,891,000 after purchasing an additional 10,000 shares during the last quarter. Finally, Dakota Wealth Management purchased a new position in Aimei Health Technology in the 4th quarter worth $406,000. 45.58% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reiterated a “sell (d+)” rating on shares of Aimei Health Technology in a research note on Wednesday, June 24th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Aimei Health Technology has a consensus rating of “Sell”.
Aimei Health Technology Trading Up 0.9%
AFJK stock opened at $11.80 on Thursday. The company’s 50 day moving average is $33.62 and its 200 day moving average is $40.27. The stock has a market cap of $37.36 million, a price-to-earnings ratio of 73.75 and a beta of 0.55. Aimei Health Technology has a 1-year low of $6.75 and a 1-year high of $130.37.
Aimei Health Technology (NASDAQ:AFJK – Get Free Report) last announced its earnings results on Tuesday, June 16th. The company reported $0.01 earnings per share (EPS) for the quarter.
About Aimei Health Technology
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.
Featured Stories
- Five stocks we like better than Aimei Health Technology
- Which Storage Stock Is Best Positioned to Win the AI Memory War?
- Tesla’s Delivery Surprise Was Big—Earnings Need to Be Bigger
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
Receive News & Ratings for Aimei Health Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aimei Health Technology and related companies with MarketBeat.com's FREE daily email newsletter.
